4-methylcatechol has been researched along with Ataxia in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Andriambeloson, E; Callizot, N; Cirillo, R; Dreano, M; Ferro, P; Glass, J; Revel, M; Vitte, PA | 1 |
1 other study(ies) available for 4-methylcatechol and Ataxia
Article | Year |
---|---|
Interleukin-6 protects against paclitaxel, cisplatin and vincristine-induced neuropathies without impairing chemotherapeutic activity.
Topics: Adenocarcinoma; Aged; Animals; Antineoplastic Agents; Ataxia; Catechols; Cisplatin; Colonic Neoplasms; Drug Evaluation, Preclinical; Female; Humans; Interleukin-6; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Neural Conduction; Neuroprotective Agents; Paclitaxel; Pain Threshold; Peripheral Nervous System Diseases; Postural Balance; Rats; Rats, Inbred Strains; Transplantation, Heterologous; Vincristine | 2008 |